High-risk elderly patients PROSPER from cholesterol-lowering therapy - PubMed (original) (raw)

Comment

High-risk elderly patients PROSPER from cholesterol-lowering therapy

Rory Collins et al. Lancet. 2002.

No abstract available

PubMed Disclaimer

Comment in

• The PROSPER trial.
  Little PJ. Little PJ. Lancet. 2003 Feb 1;361(9355):428. doi: 10.1016/S0140-6736(03)12400-2. Lancet. 2003. PMID: 12573396 No abstract available.

Comment on

• Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial.
  Shepherd J, Blauw GJ, Murphy MB, Bollen EL, Buckley BM, Cobbe SM, Ford I, Gaw A, Hyland M, Jukema JW, Kamper AM, Macfarlane PW, Meinders AE, Norrie J, Packard CJ, Perry IJ, Stott DJ, Sweeney BJ, Twomey C, Westendorp RG; PROSPER study group. PROspective Study of Pravastatin in the Elderly at Risk. Shepherd J, et al. Lancet. 2002 Nov 23;360(9346):1623-30. doi: 10.1016/s0140-6736(02)11600-x. Lancet. 2002. PMID: 12457784 Clinical Trial.

Similar articles

• The PROSPER trial.
  Mascitelli L, Pezzetta F; Prospective Study of Pravastatin in the Elderly at Risk. Mascitelli L, et al. Lancet. 2003 Feb 1;361(9355):427; author reply 428. Lancet. 2003. PMID: 12573394 No abstract available.
• [Intensive LDL lowering to under 80 mg/dl: hypercholesteremia patients with stable coronary disease and diabetes profit especially significantly].
  [No authors listed] [No authors listed] MMW Fortschr Med. 2005 Aug 18;147(33-34):50-1. MMW Fortschr Med. 2005. PMID: 16138640 German. No abstract available.
• [Lowering of cholesterol. What role is played by the choice of statins?].
  März W. März W. MMW Fortschr Med. 2004 Sep 2;146(35-36):55. MMW Fortschr Med. 2004. PMID: 15540544 German. No abstract available.
• [Lowering of LDL cholesterol prevents cardiovascular diseases. "Normal values" are too high--treatment time is a crucial factor].
  Rudling M. Rudling M. Lakartidningen. 2006 Oct 25-31;103(43):3278-82. Lakartidningen. 2006. PMID: 17117659 Review. Swedish. No abstract available.
• Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines.
  Grundy SM, Cleeman JI, Merz CN, Brewer HB Jr, Clark LT, Hunninghake DB, Pasternak RC, Smith SC Jr, Stone NJ; Coordinating Committee of the National Cholesterol Education Program. Grundy SM, et al. J Am Coll Cardiol. 2004 Aug 4;44(3):720-32. doi: 10.1016/j.jacc.2004.07.001. J Am Coll Cardiol. 2004. PMID: 15358046 Review.

Cited by

• Older type 2 diabetic patients are more likely to achieve glycaemic and cardiovascular risk factors targets than younger patients: analysis of a primary care database.
  Barrot-de la Puente J, Mata-Cases M, Franch-Nadal J, Mundet-Tudurí X, Casellas A, Fernandez-Real JM, Mauricio D. Barrot-de la Puente J, et al. Int J Clin Pract. 2015 Dec;69(12):1486-95. doi: 10.1111/ijcp.12741. Epub 2015 Sep 30. Int J Clin Pract. 2015. PMID: 26422335 Free PMC article.
• Statins for the primary prevention of cardiovascular disease.
  Taylor F, Huffman MD, Macedo AF, Moore TH, Burke M, Davey Smith G, Ward K, Ebrahim S. Taylor F, et al. Cochrane Database Syst Rev. 2013 Jan 31;2013(1):CD004816. doi: 10.1002/14651858.CD004816.pub5. Cochrane Database Syst Rev. 2013. PMID: 23440795 Free PMC article. Review.
• Diabetes in older adults: a consensus report.
  Kirkman MS, Briscoe VJ, Clark N, Florez H, Haas LB, Halter JB, Huang ES, Korytkowski MT, Munshi MN, Odegard PS, Pratley RE, Swift CS; Consensus Development Conference on Diabetes and Older Adults. Kirkman MS, et al. J Am Geriatr Soc. 2012 Dec;60(12):2342-56. doi: 10.1111/jgs.12035. Epub 2012 Oct 25. J Am Geriatr Soc. 2012. PMID: 23106132 Free PMC article. No abstract available.
• Diabetes in older adults.
  Kirkman MS, Briscoe VJ, Clark N, Florez H, Haas LB, Halter JB, Huang ES, Korytkowski MT, Munshi MN, Odegard PS, Pratley RE, Swift CS. Kirkman MS, et al. Diabetes Care. 2012 Dec;35(12):2650-64. doi: 10.2337/dc12-1801. Epub 2012 Oct 25. Diabetes Care. 2012. PMID: 23100048 Free PMC article. No abstract available.
• Effect of statins on venous thromboembolic events: a meta-analysis of published and unpublished evidence from randomised controlled trials.
  Rahimi K, Bhala N, Kamphuisen P, Emberson J, Biere-Rafi S, Krane V, Robertson M, Wikstrand J, McMurray J. Rahimi K, et al. PLoS Med. 2012;9(9):e1001310. doi: 10.1371/journal.pmed.1001310. Epub 2012 Sep 18. PLoS Med. 2012. PMID: 23028261 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science

• Medical

  • MedlinePlus Health Information